Protocol Ledger

NCT03108846 · Phase III · ACTIVE NOT RECRUITING

Escitalopram for Agitation in Alzheimer's Disease

Interventional Phase III clinical trial protocol NCT03108846 sponsored by JHSPH Center for Clinical Trials in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-01-03 Enrollment: 187 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03108846
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)187 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03108846
Protocol FieldVerified Registry Value
NCT IdentifierNCT03108846
Consolidated Lead SponsorJHSPH Center for Clinical Trials
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment187 participants (ACTUAL)
Registered Start Date2018-01-03
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI